938 research outputs found
Immune activation by combination human lymphokine-activated killer and dendritic cell therapy.
BACKGROUND: Optimal cellular immunotherapy for cancer should ideally harness both the innate and adaptive arms of the immune response. Lymphokine-activated killer cells (LAKs) can trigger early innate killing of tumour targets, whereas long-term adaptive-specific tumour control requires priming of CD8+ cytotoxic lymphocytes (CTLs) following acquisition of tumour-associated antigens (TAAs) by antigen-presenting cells such as dendritic cells (DCs). As DCs stimulate both innate and adaptive effectors, combination cell therapy using LAKs and DCs has the potential to maximise anti-tumour immune priming. METHODS: Reciprocal activation between human clinical grade LAKs and DCs on co-culture, and its immune consequences, was monitored by cell phenotype, cytokine release and priming of both innate and adaptive cytotoxicity against melanoma targets. RESULTS: Co-culture of DCs and LAKs led to phenotypic activation of natural killer (NK) cells within the LAK population, which was associated with increased production of inflammatory cytokines and enhanced innate cytotoxicity against tumour cell targets. The LAKs reciprocally matured DCs, and the combination of LAKs and DCs, on addition of melanoma cells, supported priming of specific anti-tumour CTLs better than DCs alone. CONCLUSION: Clinical-grade LAKs/DCs represents a practical, effective combination cell immunotherapy for stimulation of both innate and adaptive anti-tumour immunity in cancer patients
On the infrared behaviour of 3d Chern-Simons theories in N=2 superspace
We discuss the problem of infrared divergences in the N=2 superspace approach
to classically marginal three-dimensional Chern-Simons-matter theories.
Considering the specific case of ABJM theory, we describe the origin of such
divergences and offer a prescription to eliminate them by introducing
non-trivial gauge-fixing terms in the action. We also comment on the extension
of our procedure to higher loop order and to general three-dimensional
Chern-Simons-matter models.Comment: 26 pages, 6 figures, JHEP3; v2: minor corrections and references
added; v3: introduction expanded, presentation of section 3.3.1 improved,
references added, version to appear in JHE
Comparison of the characteristics of long-term users of electronic cigarettes versus nicotine replacement therapy: A cross-sectional survey of English ex-smokers and current smokers
Electronic cigarettes (ECs) and nicotine replacement therapy (NRT) are non-combustible nicotine delivery devices being widely used as a partial or a complete long-term substitute for smoking. Little is known about the characteristics of long-term users, their smoking behaviour, attachment to smoking, experience of nicotine withdrawal symptoms, or their views on these devices. This study aimed to provide preliminary evidence on this and compare users of the different products
Spacelike Singularities and Hidden Symmetries of Gravity
We review the intimate connection between (super-)gravity close to a
spacelike singularity (the "BKL-limit") and the theory of Lorentzian Kac-Moody
algebras. We show that in this limit the gravitational theory can be
reformulated in terms of billiard motion in a region of hyperbolic space,
revealing that the dynamics is completely determined by a (possibly infinite)
sequence of reflections, which are elements of a Lorentzian Coxeter group. Such
Coxeter groups are the Weyl groups of infinite-dimensional Kac-Moody algebras,
suggesting that these algebras yield symmetries of gravitational theories. Our
presentation is aimed to be a self-contained and comprehensive treatment of the
subject, with all the relevant mathematical background material introduced and
explained in detail. We also review attempts at making the infinite-dimensional
symmetries manifest, through the construction of a geodesic sigma model based
on a Lorentzian Kac-Moody algebra. An explicit example is provided for the case
of the hyperbolic algebra E10, which is conjectured to be an underlying
symmetry of M-theory. Illustrations of this conjecture are also discussed in
the context of cosmological solutions to eleven-dimensional supergravity.Comment: 228 pages. Typos corrected. References added. Subject index added.
Published versio
Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21
Background:
The oncolytic virus, coxsackievirus A21 (CVA21), has shown promise as a single agent in several clinical trials and is now being tested in combination with immune checkpoint blockade. Combination therapies offer the best chance of disease control; however, the design of successful combination strategies requires a deeper understanding of the mechanisms underpinning CVA21 efficacy, in particular, the role of CVA21 anti-tumor immunity. Therefore, this study aimed to examine the ability of CVA21 to induce human anti-tumor immunity, and identify the cellular mechanism responsible.
Methods:
This study utilized peripheral blood mononuclear cells from i) healthy donors, ii) Acute Myeloid Leukemia (AML) patients, and iii) patients taking part in the STORM clinical trial, who received intravenous CVA21; patients receiving intravenous CVA21 were consented separately in accordance with local institutional ethics review and approval. Collectively, these blood samples were used to characterize the development of innate and adaptive anti-tumor immune responses following CVA21 treatment.
Results:
An Initial characterization of peripheral blood mononuclear cells, collected from cancer patients following intravenous infusion of CVA21, confirmed that CVA21 activated immune effector cells in patients. Next, using hematological disease models which were sensitive (Multiple Myeloma; MM) or resistant (AML) to CVA21-direct oncolysis, we demonstrated that CVA21 stimulated potent anti-tumor immune responses, including: 1) cytokine-mediated bystander killing; 2) enhanced natural killer cell-mediated cellular cytotoxicity; and 3) priming of tumor-specific cytotoxic T lymphocytes, with specificity towards known tumor-associated antigens. Importantly, immune-mediated killing of both MM and AML, despite AML cells being resistant to CVA21-direct oncolysis, was observed. Upon further examination of the cellular mechanisms responsible for CVA21-induced anti-tumor immunity we have identified the importance of type I IFN for NK cell activation, and demonstrated that both ICAM-1 and plasmacytoid dendritic cells were key mediators of this response.
Conclusion:
This work supports the development of CVA21 as an immunotherapeutic agent for the treatment of both AML and MM. Additionally, the data presented provides an important insight into the mechanisms of CVA21-mediated immunotherapy to aid the development of clinical biomarkers to predict response and rationalize future drug combinations
- …